Comparison

SHP2 protein degrader-2 European Partner

€11,019.00
Excl. VAT
Item no. HY-145703-100mg
Manufacturer MedChem Express
CASRN 2740582-16-3
Amount 100 mg
Category
Type Proteins Recombinant
Specific against other
Purity 99.76
Formula C56H79ClN12O6S2
Citations [1]Song Y, et al. Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy. J Med Chem. 2022 Feb 24;65(4):3066-3079.
Smiles ClC(C(SC1=NC=C(N2CCC(N)(CC2)C)N=C1N)=CC=C3)=C3NC(CCC(N(CC4)CCN4CCCCCCCCC(N[C@H](C(C)(C)C)C(N5[C@H](C[C@@H](C5)O)C(N[C@@H](C6=CC=C(C7=C(C)N=CS7)C=C6)C)=O)=O)=O)=O)=O
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Product Description
SHP2 protein degrader-2 (SHP2-D26) is a SHP2 protein PROTAC degrader. SHP2 protein degrader-2 reduces expression level of SHP2 in various cancer cells[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
Molecular Weight
1115.89
Clinical Information
No Development Reported
Solubility
DMSO : 100 mg/mL (ultrasonic)
Pathway
Metabolic Enzyme/Protease; PROTAC; Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
Listprice: €11,019.00
Price: €11,019.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close